- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
Introgen Therapeutics, Inc.
(NASDAQ:INGN)- View:
- Quarterly Data
- Annual Data
- Note: All numbers in thousands
| Sep 30, 2008 | Jun 30, 2008 | Mar 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & Equivalents | 6,294 | 11,016 | 16,479 | 11,320 |
| Restricted Cash | — | — | — | — |
| Marketable Securities | — | — | — | 13,750 |
| Accounts Receivable | — | — | — | — |
| Loans Receivable | — | — | — | — |
| Other Receivable | — | — | — | — |
| Receivables | — | — | — | — |
| Raw Materials | — | — | — | — |
| Work in Progress | — | — | — | — |
| Purchased Components | — | — | — | — |
| Finished Goods | — | — | — | — |
| Other Inventories | — | — | — | — |
| Inventories Adjustments and Allowances | — | — | — | — |
| Inventories | — | — | — | — |
| Prepaid Expenses | 388 | 535 | 462 | 706 |
| Current Deferred Income Taxes | — | — | — | — |
| Other Current Assets | — | — | — | — |
| Total Current Assets | 6,682 | 11,551 | 16,941 | 25,776 |
| Land and Improvements | — | — | — | — |
| Building and Improvements | — | — | — | 12,800 |
| Machinery Furniture and Equipment | — | — | — | 6,636 |
| Construction in Progress | — | — | — | — |
| Other Fixed Assets | 19,598 | 19,563 | 19,315 | — |
| Total Fixed Assets | 19,598 | 19,563 | 19,315 | 19,436 |
| Gross Fixed Assets | 19,598 | 19,563 | 19,315 | 19,436 |
| Accumulated Depreciation and Depletion | 15,740 | 15,489 | 14,994 | 14,994 |
| Net Fixed Assets | 3,858 | 4,074 | 4,321 | 4,442 |
| Intangibles | — | — | — | — |
| Cost in Excess | — | — | — | — |
| Non Current Deferred Income Taxes | — | — | — | — |
| Other Non Current Assets | 245 | 253 | 260 | 265 |
| Total Non Current Assets | 4,103 | 4,327 | 4,581 | 4,707 |
| Total Assets | 10,785 | 15,878 | 21,522 | 30,485 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | 2,582 | 2,881 | 3,045 | 1,813 |
| Notes Payable | 517 | 544 | 553 | — |
| Short Term Debt | — | — | — | 586 |
| Accrued Expenses | — | — | — | — |
| Accrued Liabilities | 2,589 | 2,450 | 2,768 | 4,225 |
| Deferred Revenues | 709 | 599 | 537 | 616 |
| Current Deferred Income Tax Liabilities | — | — | — | — |
| Other Current Liabilities | — | — | — | — |
| Total Current Liabilities | 6,397 | 6,474 | 6,903 | 7,240 |
| Non Current Liabilities | ||||
| Long Term Debt | 6,897 | 7,022 | 7,014 | 7,155 |
| Capital Lease Obligations | — | — | — | — |
| Deferred Income Tax Liabilities | — | — | — | — |
| Other Non Current Liabilities | — | 6 | 22 | 79 |
| Minority Interest Liabilities | — | 2 | 2 | 6 |
| Preferred Securities of Subsidiary Trust Liabilities | — | — | — | — |
| Preferred Equity Outside Stock Equity | — | — | — | — |
| Total Non Current Liabilities | 13,294 | 13,504 | 13,941 | 14,480 |
| Total Liabilities | 6,897 | 7,030 | 7,038 | 7,240 |
| Shareholders' Equity | ||||
| Preferred Stock Equity | — | — | — | — |
| Common Stock Equity | -2,511 | 2,374 | 7,581 | 16,003 |
| Common Par | 44 | 44 | 44 | 44 |
| Additional Paid in Capital | 214,946 | 213,766 | 212,622 | 211,558 |
| Cumulative Translation Adjustment | — | — | — | — |
| Retained Earnings | -217,437 | -211,462 | -205,116 | -202,715 |
| Treasury Stock | — | — | — | — |
| Other Equity Adjustments | -64 | 26 | 31 | 7,116 |
| Total Capitalization | 4,386 | 9,396 | 14,595 | 23,158 |
| Cash Flow | -23,289 | -24,868 | -26,253 | -29,437 |
| Working Capital | 285 | 5,077 | 10,038 | 18,536 |
| Free Cash Flow | -15,549 | -11,042 | -5,664 | -24,234 |
| Invested Capital | 4,386 | 9,396 | 14,595 | 23,158 |
| Total Equity | -2,511 | 2,374 | 7,581 | 16,003 |
| Total Liabilities and Stock Equity | 10,783 | 15,878 | 21,522 | 30,483 |